Pancreatic Cancer (PANC)

  • Trial ID: PANC003 | NCT03504423
  • Last Updated: 2 June, 2020

Clinical Trial PANC003: Patients with Metastatic Adenocarcinoma of the Pancreas

The purpose of this study is to evaluate the efficacy and safety of FFX versus mFFX in combination with CPI-613®.

  • 70 Sites

For Patients

Get information about indications and participating in clinical trials that match your diagnoses.

More Info

For Physicians

Learn about treatments and read the latest news and resources for health professionals.

More Info

Have questions? Live support is available 24/7 - Call (609) 409 7050 or Email Us